“REBOUND OBESITY AFTER GLP-1 AGONISTS DISCONTINUATION”. Global Journal of Public Health Medicine, vol. 7, no. 1, July 2025, pp. 208-15, https://doi.org/10.37557/gjphm.v7i1.336.